Yang Xiang to Methotrexate
This is a "connection" page, showing publications Yang Xiang has written about Methotrexate.
Connection Strength
0.401
-
Xiang Y, Pan BH, Zhang J, Chen JQ, Fang H, Wang Q, Li LH, Chen TS, Chen JX, Li C, Zheng XF, Zhu SH. Suppression of overactivated immunity in the early stage is the key to improve the prognosis in severe burns. Front Immunol. 2024; 15:1455899.
Score: 0.208
-
Jiang F, Mao MY, Xiang Y, Lu X, Guan CL, Jiao LZ, Wan XR, Feng FZ, Ren T, Yang JJ, Zhao J. Comparing biweekly single-dose actinomycin D with multiday methotrexate therapy for low-risk gestational trophoblastic neoplasia (FIGO Score 0-4): study protocol for a prospective, multicentre, randomized trial. BMC Cancer. 2023 Aug 23; 23(1):784.
Score: 0.193